-+ 0.00%
-+ 0.00%
-+ 0.00%

Samsung C&T Stake in Samsung Biologics Falls to 42.66% From 43.06%

PUBT·11/20/2026 09:10:23
Listen to the news
Samsung C&T Stake in Samsung Biologics Falls to 42.66% From 43.06%
  • Samsung C&T's stake in Samsung Biologics fell to 42.66% from 43.06% on Nov. 18, 2026.
  • Holdings rose by 782,818 common shares to 20,715,168 through a rights offering priced at 1.17 million won per share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Samsung Biologics Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261120000596), on November 20, 2026, and is solely responsible for the information contained therein.